Literature DB >> 10092168

An overlap syndrome with features of atypical Cogan syndrome and Wegener's granulomatosis.

J T Gran1, B Y Nordvåg, B Storesund.   

Abstract

A 48 year old women developed serous otitis, scleritis, myalgia, vertigo, polyneuropathy, crescentic glomerulonephritis, general cerebral dysrythmia, hilar adenopathy, and retroorbital granulomatous inflammation. Pulmonary manifestations were absent and antibodies against neutrophilic cytoplasmic antigens (ANCA) could not be detected. The clinical picture was classified as an overlap syndrome with features of both atypical Cogan syndrome and Wegener's granulomatosis. The patient responded to treatment with high dose corticosteroids and pulse cyclophosphamide.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10092168     DOI: 10.1080/03009749950155823

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  5 in total

Review 1.  Non-infectious orbital vasculitides.

Authors:  B Perumal; E H Black; F Levin; J J Servat
Journal:  Eye (Lond)       Date:  2012-02-24       Impact factor: 3.775

Review 2.  Cogan's syndrome and other ocular vasculitides.

Authors:  Gabriela M Espinoza; Angela Prost
Journal:  Curr Rheumatol Rep       Date:  2015-04       Impact factor: 4.592

Review 3.  Optimal management of Cogan's syndrome: a multidisciplinary approach.

Authors:  Vittorio D'Aguanno; Massimo Ralli; Marco de Vincentiis; Antonio Greco
Journal:  J Multidiscip Healthc       Date:  2017-12-22

Review 4.  Autoimmune Inner Ear Disease: Immune Biomarkers, Audiovestibular Aspects, and Therapeutic Modalities of Cogan's Syndrome.

Authors:  Oded Shamriz; Yuval Tal; Menachem Gross
Journal:  J Immunol Res       Date:  2018-04-23       Impact factor: 4.818

5.  Childhood Cogan syndrome with aortitis and anti-neutrophil cytoplasmic antibody-associated glomerulonephritis.

Authors:  Keisuke Sugimoto; Tomoki Miyazawa; Hitomi Nishi; Akane Izu; Takuji Enya; Mitsuru Okada; Tsukasa Takemura
Journal:  Pediatr Rheumatol Online J       Date:  2014-04-25       Impact factor: 3.054

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.